MIR4529: A Potential Drug Target and Biomarker (G100616290)
MIR4529: A Potential Drug Target and Biomarker
Molecular medicine has made significant progress in the past decade, and one promising target in the field is MIR4529. MIR4529 is a non-coding RNA molecule that has been shown to play a critical role in various cellular processes, including cell growth, survival, and angiogenesis. Researchers have now identified several potential drug targets based on MIR4529, which may lead to new treatments for various diseases.
The MIR4529 gene
MIR4529 is a non-coding RNA molecule that was first identified in the genomics database. It is located on chromosome 6 and has a length of 219 nucleotides. MIR4529 is expressed in various tissues of the body, including the brain, heart, liver, and pancreas.
MIR4529 functions as a negative regulator of the microRNA (miRNA) pathway. The miRNA pathway is a complex process that regulates gene expression by using small non-coding RNAs called miRNAs. MIR4529 is a critical regulator of the miRNA pathway, and it has been shown to play a role in various cellular processes.
MIR4529 regulates the miRNA pathway by binding to specific target miRNAs. It has been shown to interact with several well-known miRNAs, including miR-18a, miR-202, and miR-21. MIR4529 has also been shown to regulate the expression of its own miRNA, MIR-4529-containing RNA (MIR-4529-RNA).
MIR4529's role in cancer
MIR4529 has been shown to play a critical role in the development and progression of cancer. It has been shown to be involved in various cellular processes that promote cancer cell growth, survival, and angiogenesis.
One of the most significant functions of MIR4529 is its role in cell survival. Studies have shown that MIR4529 can prevent apoptosis (programmed cell death) in cancer cells, which may contribute to their survival. MIR4529 has also been shown to promote the growth and survival of cancer cells in various models, including mouse models of breast, lung, and colorectal cancer.
MIR4529's role in angiogenesis
MIR4529 has also been shown to play a critical role in the process of angiogenesis, which is the process by which new blood vessels are formed in the body. MIR4529 has been shown to regulate the production of new blood vessels in the brain, which may contribute to the development of brain tumors.
MIR4529's potential as a drug target
Based on the above findings, MIR4529 has now been identified as a potential drug target for various diseases. Researchers have identified several potential drug targets based on MIR4529, including targets for cancer, neurodegenerative diseases, and cardiovascular diseases.
MIR4529 as a cancer drug target
One of the most promising potential drug targets for MIR4529 is its role in cancer. Researchers have identified several cancer cell types that are highly sensitive to MIR4529, including breast, lung, and colorectal cancer. MIR4529 has been shown to promote the growth and survival of cancer cells, which may contribute to their development and progression.
MIR4529 has also been shown to regulate the production of new blood vessels in cancer cells, which may contribute to their ability to access oxygen and nutrients. This may also contribute to the development of
Protein Name: MicroRNA 4529
The "MIR4529 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4529 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723
